Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium

Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award

Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )

EHA 2015: Expert opinions on new treatment standard in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry...

EHA 2015: Expert opinions on new treatment standard in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon )

Advances in the treatment and management of CLL

Prof Clemens Wendtner and Prof Peter Hillmen

Advances in the treatment and management of CLL ( Prof Clemens Wendtner and Prof Peter Hillmen )

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

Dr Emiliano Calvo - START Madrid, Madrid, Spain

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer ( Dr Emiliano Calvo - START Madrid, Madrid, Spain )

Expert overview on the recent developments in mantle cell lymphoma

Professor Gordon McVie and Professor Simon Rule

Expert overview on the recent developments in mantle cell lymphoma ( Professor Gordon McVie and Professor Simon Rule )

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer

Dr Simon Chowdhury - Guy's Hospital, London, UK

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer ( Dr Simon Chowdhury - Guy's Hospital, London, UK )

Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma

Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium

Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )

ASCO 2015: Latest developments in multiple myeloma

Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos

ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )

ASCO 2015: Latest in chronic lymphocytic leukaemia

Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos

ASCO 2015: Latest in chronic lymphocytic leukaemia ( Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos )

Comment: Eribulin extends overall survival for advanced liposarcoma and...

Prof Gary Schwartz - Columbia University, New York, USA

Comment: Eribulin extends overall survival for advanced liposarcoma and leiomyosarcoma ( Prof Gary Schwartz - Columbia University, New York, USA )

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...

Dr William Slayton - University of Florida, Gainsville, USA

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )

More from ecancer